| Name | MSX-122 |
| Synonyms | MSX122 CS-2430 MSX 222 MSX 122 MSX-122 1,4-Benzenedimethanamine, N1,N4-di-2-pyrimidinyl- N-[[4-[(pyrimidin-2-ylamino)methyl]phenyl]methyl]pyrimidin-2-amine |
| CAS | 897657-95-3 |
| Molecular Formula | C16H16N6 |
| Molar Mass | 292.35 |
| Density | 1.313±0.06 g/cm3(Predicted) |
| Melting Point | 219 °C |
| Boling Point | 566.9±60.0 °C(Predicted) |
| Solubility | 10 mM in DMSO |
| pKa | 3.82±0.10(Predicted) |
| Storage Condition | -20℃ |
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 3.421 ml | 17.103 ml | 34.207 ml |
| 5 mM | 0.684 ml | 3.421 ml | 6.841 ml |
| 10 mM | 0.342 ml | 1.71 ml | 3.421 ml |
| 5 mM | 0.068 ml | 0.342 ml | 0.684 ml |
| biological activity | MSX-122 is a new type of CXCR4 partial antagonist with an IC50 of about 10 nM. |
| target | TargetValue CXCR4 () ~ 10 nM |
| Target | Value |
| CXCR4 () | ~10 nM |